Search Results - "GEHAN, E. A"

The Third Intergroup Rhabdomyosarcoma Study by Crist, W, Gehan, E A, Ragab, A H, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J, Heyn, R

“…The ultimate goal of the Third Intergroup Rhabdomyosarcoma Study (IRS-III, 1984 to 1991) was to improve treatment outcome in children with rhabdomyosarcoma…”
Get more information

Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991 by Raney, R B, Asmar, L, Newton, Jr, W A, Bagwell, C, Breneman, J C, Crist, W, Gehan, E A, Webber, B, Wharam, M, Wiener, E S, Anderson, J R, Maurer, H M

“…One hundred thirty of 2,792 patients (5%) registered on three Intergroup Rhabdomyosarcoma Study clinical trials (IRS-I, -II, and -III) from 1972 to 1991 had an…”
Get more information

Expression profile of long-noncoding RNAs MIR31HG, NKILA, and PACER in systemic lupus erythematosus patients by Alrefai, Abeer A., Abouelenin, Mai A.H., Salman, Maha M.A., Tawfeek, Gehan A.E., Abbas, Mona A.

“…Growing evidence suggests that systemic lupus erythematosus (SLE), an organ-damaging systemic autoimmune illness, may be influenced by long-noncoding RNAs…”
Get full text

The Intergroup Rhabdomyosarcoma Study-II by Maurer, H M, Gehan, E A, Beltangady, M, Crist, W, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J

“…Intergroup Rhabdomyosarcoma Study (IRS)-II, (1978-1984) had the general goals of improving the survival and treatment of children with rhabdomyosarcoma (RMS)…”
Get more information

The role of the biostatistician in cancer research by Gehan, E.A.

“…This article considers triumphs and challenges for biostatisticians working in oncology at the beginning of the 21st century. The impact of three major…”
Get full text

Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study by Nesbit, Jr, M E, Gehan, E A, Burgert, Jr, E O, Vietti, T J, Cangir, A, Tefft, M, Evans, R, Thomas, P, Askin, F B, Kissane, J M

“…A total of 342 previously untreated eligible children were entered into the first Intergroup Ewing's Sarcoma Study (IESS) between May 1973 and November 1978…”
Get more information

Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II by Burgert, Jr, E O, Nesbit, M E, Garnsey, L A, Gehan, E A, Herrmann, J, Vietti, T J, Cangir, A, Tefft, M, Evans, R, Thomas, P

“…Two hundred fourteen eligible patients with previously untreated, localized Ewing's sarcoma of bone were randomized on IESS-II to receive Adriamycin (ADR;…”
Get more information

On the ethical aspects of the testimony of statisticians in court by Gehan, E A

“…This article considers a legal case presented by the Gore campaign to the Florida Eleventh Circuit Court in December 2000 to contest the election results…”
Get full text

The Intergroup Rhabdomyosarcoma Study-I. A final report by Maurer, H M, Beltangady, M, Gehan, E A, Crist, W, Hammond, D, Hays, D M, Heyn, R, Lawrence, W, Newton, W, Ortega, J

“…The results of treatment of 686, previously untreated patients younger than 21 years with rhabdomyosarcoma or undifferentiated sarcoma, who were entered on…”
Get more information

Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome by Keating, M J, Smith, T L, Kantarjian, H, Cork, A, Walters, R, Trujillo, J M, McCredie, K B, Gehan, E A, Freireich, E J

“…An analysis was conducted of clinical and laboratory variables associated with response to remission induction therapy and remission duration in 440 patients…”
Get more information

Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study by Evans, R G, Nesbit, M E, Gehan, E A, Garnsey, L A, Burgert, Jr, O, Vietti, T J, Cangir, A, Tefft, M, Thomas, P, Askin, F B

“…A total of 59 eligible patients with localized Ewing's sarcoma of the pelvic and sacral bones were entered into a multimodal Intergroup Ewing's Sarcoma Study…”
Get more information

Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer by MEEHAN, K. R, ARUN, B, GEHAN, E. A, BERBERIAN, B, SULICA, V, AREMAN, E. M, MAZUMDER, A, LIPPMAN, M. E

“…We previously demonstrated findings suggestive of autologous GVHD in patients receiving IL-2-activated peripheral blood stem cells (PBSC) with IL-2 after…”
Get full text

Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II by Wharam, M D, Hanfelt, J J, Tefft, M C, Johnston, J, Ensign, L G, Breneman, J, Donaldson, S S, Fryer, C, Gehan, E A, Raney, R B, Maurer, H M

“…A subset of 362 pediatric patients with rhabdomyosarcoma was selected from a total of 532 eligible IRS-II patients in Clinical Group III to assess the local…”
Get more information

Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer : Investigation of dose level with clinical correlates by MEEHAN, K. R, VERMA, U. N, MAZUMDER, A, CAHILL, R, FRANKEL, S, AREMAN, E. M, SACHER, R. A, FOELBER, R, RAJAGOPAL, C, GEHAN, E. A, LIPPMAN, M. E

“…Incubating hematopoietic stem cells with IL-2 in vitro for 24 h generates cytotoxic T cells. When infused into patients, these cells may stimulate a…”
Get full text

Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II) by Lawrence, Jr, W, Gehan, E A, Hays, D M, Beltangady, M, Maurer, H M

“…The need for a pretreatment staging system to accurately assess programs of therapy for the various sites and stages of childhood rhabdomyosarcoma has become…”
Get more information

The scientific basis of clinical trials: statistical aspects by Gehan, E A

“…The objective of this paper is to delineate some of the advances in clinical oncology that have occurred since the 1950s in the context of methodological…”
Get full text

Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study by Donaldson, S S, Asmar, L, Breneman, J, Fryer, C, Glicksman, A S, Laurie, F, Wharam, M, Gehan, E A

“…The Intergroup Rhabdomyosarcoma Study (IRS) Group initiated a pilot study (IRS IV-P) of hyperfractionated radiation (HF XRT) with chemotherapy to test the…”
Get more information

Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia by Estey, E, Smith, T L, Keating, M J, McCredie, K B, Gehan, E A, Freireich, E J

“…Among 569 patients with newly diagnosed AML, 16% died in the 4 weeks following initiation of remission induction therapy. Eight pretreatment characteristics…”
Get more information

Will There Be Resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)? by Gehan, Edmund A., Tefft, Mariella C.

“…Since the 1950s, there have been concerns about the definition of response in solid tumors and the reliance on quantitative measurements. Gehan and Tefft…”
Get full text

Pretreatment TNM staging of childhood Rhabdomyosarcoma : A report of the Intergroup Rhabdomyosarcoma Study Group by LAWRENCE, W. JR, ANDERSON, J. R, GEHAN, E. A, MAURER, H

Get full text